8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Paralysis in 1 studies
8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asmundsson, G | 1 |
Caringi, D | 1 |
Mokler, DJ | 1 |
Kobayashi, T | 1 |
Ishide, T | 1 |
Ally, A | 1 |
1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Paralysis
Article | Year |
---|---|
Extracellular serotonin changes in VLM during muscle contraction: effects of 5-HT1A-receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Pressure; Electric Stimulation; Heart Rate; K | 1997 |